Vigon International’s founder and president, Steve Somers, is a finalist in the Greater Philadephia area for the EY Entrepreneur Of The Year 2016 Awards. Vigon just won BFTP/NEP’s Manufacturing Achievement Innovation Award at the May 2016 iXchange. Read more: http://bit.ly/28J9ZmR
Micro Interventional Devices, Inc.™ (MID), the world leader in minimally invasive and catheter-based compliant fixation technology, received CE Mark approval for its Permaseal™ transapical access and closure device. This disruptive technology simplifies cardiovascular surgery, allowing surgeons to access and close the left-ventricle instantaneously, reliably, and without suturing the myocardium. Read more: http://prn.to/1OddZ25
Bridgeworks Enterprise Center, a member of the Ben Franklin Business Incubator Network, has launched a new microloan program specifically for business incubator clients. Read more: http://bit.ly/1Y62gUN
U.S. Sen. Bob Casey of Pennsylvania visited BFTP alum OraSure Technologies to call for a proactive approach from Congress to acquire the $1.9 billion in emergency appropriations funds he said are needed to fight Zika and allow companies such as OraSure to develop tests to diagnose it. Via Lehigh Valley Business; via Morning Call.
The top two clinics identified as the Best IVF Programs in the U.S. by FertilitySuccessRates.com are protected by the LifeAire Systems’s Technology: Gold Coast IVF (Woodbury, NY) and The Center for Reproductive Medicine (Mobile, AL). Read more: http://bit.ly/253IiMv
Radius Corporation earned the President’s “E” Award for Exports, the highest recognition any U.S. entity can receive for making a significant contribution to the expansion of U.S. exports. Read more: http://bit.ly/1TnuyHk
Cernostics, Inc. announced that findings from three scientific studies of its new TissueCypher® Barrett’s Esophagus Assay will be presented at the Digestive Disease Week (DDW) meeting in San Diego. DDW is the world’s largest conference on Gastro-intestinal Medicine. Cernostics’ TissueCypher® Barrett’s Esophagus Assay is the first clinical assay of its kind to predict the risk of developing esophageal cancer. Read more: http://bit.ly/1TRFTiQ
Azevan Pharmaceuticals, Inc. (www.azevan.com), which is developing novel small molecule medicines for disorders of stress, mood, and behavior, announced that enrollment has been completed in a Phase 2 clinical study of the company’s lead compound SRX246 in adults with DSM-5 Intermittent Explosive Disorder. Read more: http://prn.to/1X1HV2d
Innovative Control Systems (ICS), a provider of carwash management and control system technologies announced it has acquired PSD Codax, a global designer/manufacturer of carwash code entry and access control systems. Kevin Detrick, Continue Reading ...
Ben Franklin Technology Partners
of Northeastern Pennsylvania
116 Research Drive
Bethlehem, PA 18015
Designed & Developed by Altitude Marketing
The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and
Economic Development and is funded by the Ben Franklin Technology Development Authority.